inflammation

LIVE October 12th, 2021 at 11:30 AM ET

Bill Thelin will discuss how intestine-on-a chip technology reliably models gastrointestinal disease and assists researchers in screening for safe, effective therapeutic candidates.

Unlike other cells in the body that mount a strong immune response against microbial invaders, skin cells use an epigenetic mechanism to ignore most of the microbes they see. These findings reveal a potential new drug target for inflammatory skin diseases.

From microgravity to radiation, space wreaks havoc on astronauts’ immune systems, potentially putting them at risk of infection from microbes onboard.

THE MANY TYPES OF MACROPHAGES

Exercising lab-grown human muscle can block the effects of interferon gamma

Data supporting Applied Molecular Transport's AMT-101 in treating inflammatory diseases published in The Journal of Immunology

Study suggests that future asthma therapies should target OX40L and CD30L